Nkcfo LLC Gilead Sciences, Inc. Transaction History
Nkcfo LLC
- $215 Million
- Q1 2025
A detailed history of Nkcfo LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nkcfo LLC holds 44,145 shares of GILD stock, worth $5.04 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
44,145
Previous 29,655
48.86%
Holding current value
$5.04 Million
Previous $2.74 Million
80.58%
% of portfolio
2.3%
Previous 1.2%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,296Shares Held
1BCall Options Held
9.6MPut Options Held
10.1M-
Black Rock Inc. New York, NY121MShares$13.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.4 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.8 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.24 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.12 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $143B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...